Supplementary Material - Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Published: 29 November 2022| Version 1 | DOI: 10.17632/vnfbmxpx22.1
Contributors:
Lisa Beck,
Thomas Bieber,
Stephan Weidinger,
Marie Tauber,
Hidehisa Saeki,
Alan Irvine,
Lawrence Eichenfield,
Thomas Werfel ,
Petra Arlert,
Li J,
Mads Røpke,
Amy Paller

Description

Supplementary Information to accompany and support the manuscript: Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.

Files

Categories

Dermatology, Microbiome, Clinical Trial, Atopic Dermatitis

Funding

LEO Pharma

License